December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Srinivas Rao

Recent news which mentions Srinivas Rao

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Tickers ATAI DMT MDMA NEWS
Tags Psychedelics Research ATAI Life Sciences Ibogaine
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Tickers ATAI ENVB NEWS
Tags Srinivas Rao Cannabis Psychedelics
From Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags Benzinga Florian Brand ATAI Life Sciences
From Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Tickers ATAI HTGC
Tags Mid Cap Psychedelics Markets
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags MSSTF PSYBF Dr/ Tiago Reis Marques
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.